ORCID as entered in ROS

Select Publications
2024, Engineered paediatric tumours retain maintains tumour genotype and phenotype for precision medicine, http://dx.doi.org/10.1101/2024.11.17.619539
,2022, A 3D bioprintable hydrogel with tuneable stiffness for exploring cells encapsulated in matrices of differing stiffnesses, http://dx.doi.org/10.1101/2022.10.06.511222
,2022, βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer, http://dx.doi.org/10.1101/2022.09.29.510034
,2021, A covalently crosslinked bioink for multi-materials drop-on-demand 3D bioprinting of three-dimensional cell cultures, http://dx.doi.org/10.1101/2021.02.18.431759
,2021, A high-throughput 3D bioprinted cancer cell migration and invasion model with versatile and broad biological applicability, http://dx.doi.org/10.1101/2021.12.28.474387
,2021, High temporal resolution RNA-seq time course data reveals mammalian lncRNA activation mirrors neighbouring protein-coding genes, http://dx.doi.org/10.1101/2021.08.25.457323
,2021, Spatial-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density, http://dx.doi.org/10.1101/2021.10.26.465839
,A 3D Bioprinter Specifically Designed for the High-Throughput Production of Matrix-Embedded Multicellular Spheroids, http://dx.doi.org/10.2139/ssrn.3646560
,